Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

37.66
Delayed Data
As of Sep 22
 -0.06 / -0.16%
Today’s Change
29.83
Today|||52-Week Range
50.10
-16.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line354.7M362.0M305.0M179.6M
 
 
 
 
 
Depreciation117.2M132.2M156.2M168.3M
 
 
 
 
 
Total Other Cash Flow17.3M155.4M175.8M48.5M
 
 
 
 
 
Funds From Operations489.2M649.5M637.0M396.4M
 
 
 
 
 
Funds From/For Other Operating Expenses171.3M245.5M2.9M79.8M
 
 
 
 
 
Net Cash Flow - Operating Activities317.9M404.1M634.2M316.5M
 
 
 
 
 
 
InvestingIncrease In Investments-738.9M-872.6M-1.0B-742.1M
 
 
 
 
 
Decrease In Investments622.0M737.3M1.1B1.1B
 
 
 
 
 
Capital Expenditures-166.2M-152.4M-183.1M-183.2M
 
 
 
 
 
Fixed Asset Disposal1.4M2.8M1.3M656.5K
 
 
 
 
 
Net Assets From Acquisitions 0.00-4.5M-120.9M-253.6K
 
 
 
 
Other Investing - Sources478.2K0.000.000.00
 
 
Net Cash Flow Investing-290.3M-387.1M-330.8M-285.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-15.5M66.4M-4.2M322.6M
 
 
 
 
 
Long Term Borrowings166.5M0.000.000.00
 
 
Long Term Debt Reduction-87.1M-60.6M-178.4M-77.9M
 
 
 
 
 
Net Proceeds Stock Sale33.0K3.4M15.2K14.9K
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-234.2M
 
 
Common Dividends-49.2M-58.5M-62.6M-50.6M
 
 
 
 
 
Cash Dividends Paid - Total-49.2M-58.5M-62.6M-50.6M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing412.3K0.000.000.00
 
 
Net Cash Flow - Financing14.3M-49.4M-245.1M-40.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash12.7M-17.4M-65.5M-7.3M
 
 
 
 
 
 
Net Change In Cash42.0M-32.5M58.3M-8.4M